Yes, you CAN survive a lung cancer diagnosis. Exciting new treatments for lung cancer are being discovered that may be used alone, before or after, or in combination with traditional chemotherapy, radiation and surgery.

Lung Cancer Foundation of America is working to change the public perceptions of lung cancer through education and personal stories of those impacted by this leading cause of death in cancer. These stories bring special attention to specific health conditions associated closely with lung cancer.

Read Their Stories

Celebrate with us the stories of these brave Lung Cancer Heroes. While they are not here to tell their stories themselves, these Heroes inspire us and motivate us to keep fighting this disease every day and in every way.

Read Their Stories

Targeted Therapies

Researchers are learning more about what makes lung cancer cells form, grow, and spread. Every cell in the body has the same library of genes that acts as the blueprint for everything else that makes up a cell and makes it work. In cancer cells, damage to these genes (mutations) is responsible for the cells becoming cancerous. Some of these mutations create proteins in cells that act like a stuck gas pedal in your car to make it drive out of control. These mutant proteins in cancer cells are good “targets” for new drugs. These drugs are known as TARGETED THERAPIES.    Targeted therapies work by blocking these mutant proteins, which prevents them from growing and spreading, while not harming normal cells. Tarceva® (Erlotinib), Gilogrif® (Afatanib), Xalkori® (Crizotinib) and Zykadia® (Ceritinib) are examples of FDA-approved drugs that target the mutated proteins, some of which are referred to as “receptors” that are driving the cancer cells out of control.

Learn more


A New and Exciting Frontier In The Treatment of Lung Cancer is the Field of “Immunotherapy.”